a year ago
GEHC
AnalystsDavid RomanDavid Roman's Stock Forecasts
AnalystsDavid Roman
Analyst Ranking
Bottom 6%
#4918 out of 5185 analysts
Average Return
-5.28%
Win Rate
34%12 out of 35
Risk vs Reward
Poor
Good
David Roman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Livanova PLCLIVN | +57.50% | $41.72 | $65.71 | 2025-03-02 - 2026-01-30 | Strong Buy |
Doximity IncDOCS | +46.96% | $70.64 | $37.47 | 2025-09-30 - 2026-01-30 | Strong Sell |
Glaukos CorpGKOS | +43.50% | $83.19 | $119.38 | 2025-09-30 - 2026-01-30 | Strong Buy |
Boston Scientific CorpBSX | +39.33% | $75.00 | $104.50 | 2024-05-29 - 2025-05-29 | Strong Buy |
Intuitive Surgical IncISRG | +37.77% | $403.39 | $555.75 | 2024-05-29 - 2025-05-29 | Strong Buy |
David Roman Analyst Color
Get additional color on David Roman's coverage of popular stocks
David Roman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Medline IncMDLN | 1 | Strong Buy | $49.00 | +10.86% | Initiates Coverage On | 19 days ago |
Healthequity IncHQY | 4 | Strong Sell | $89.00 | +3.89% | Downgrades | 22 days ago |
Kestra Medical Technologies LtdKMTS | 3 | Hold | $25.00 | +1.34% | Maintains | 2 months ago |
Cooper Companies IncCOO | 2 | Strong Sell | $71.00 | -12.75% | Maintains | 2 months ago |
Medtronic PLCMDT | 2 | Hold | $111.00 | +7.81% | Upgrades | 2 months ago |
Irhythm Technologies IncIRTC | 4 | Hold | $202.00 | +30.74% | Maintains | 3 months ago |
Edwards Lifesciences CorpEW | 4 | Strong Buy | $104.00 | +27.83% | Maintains | 3 months ago |
Baxter International IncBAX | 4 | Hold | $22.00 | +9.62% | Maintains | 3 months ago |
Beta Bionics IncBBNX | 3 | Strong Buy | $33.00 | +138.61% | Maintains | 3 months ago |
Bausch & Lomb CorpBLCO | 1 | Hold | $16.00 | -4.19% | Initiates Coverage On | 4 months ago |
Glaukos CorpGKOS | 1 | Strong Buy | $103.00 | -13.72% | Initiates Coverage On | 4 months ago |
Doximity IncDOCS | 4 | Strong Sell | $64.00 | +70.80% | Downgrades | 4 months ago |
Shoulder Innovations IncSI | 1 | Strong Buy | $20.00 | +41.24% | Initiates Coverage On | 5 months ago |
Carlsmed IncCARL | 1 | Strong Buy | $19.00 | +52.98% | Initiates Coverage On | 5 months ago |
Omada Health IncOMDA | 1 | Strong Buy | $29.00 | +93.98% | Initiates Coverage On | 7 months ago |
Insulet CorpPODD | 1 | Strong Buy | $380.00 | +48.55% | Initiates Coverage On | 8 months ago |
Zimmer Biomet Holdings IncZBH | 2 | Hold | $104.00 | +19.44% | Maintains | 9 months ago |
Teladoc Health IncTDOC | 4 | Strong Buy | $10.00 | +83.49% | Maintains | 9 months ago |
Ge Healthcare Technologies IncGEHC | 3 | Strong Buy | $82.00 | +3.84% | Maintains | 9 months ago |
Abbott LaboratoriesABT | 2 | Strong Buy | $154.00 | +40.90% | Maintains | a year ago |
Tandem Diabetes Care IncTNDM | 2 | Hold | $24.00 | +20.66% | Maintains | a year ago |
Solventum CorpSOLV | 4 | Strong Sell | $71.00 | -7.76% | Maintains | a year ago |
Livanova PLCLIVN | 2 | Strong Buy | $55.00 | -16.30% | Maintains | a year ago |
Stryker CorpSYK | 2 | Hold | $427.00 | N/A | Maintains | a year ago |
Boston Scientific CorpBSX | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 2 years ago |
Intuitive Surgical IncISRG | 1 | Strong Buy | $500.00 | N/A | Initiates Coverage On | 2 years ago |
Becton Dickinson & CoBDX | 1 | Strong Buy | $274.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.